|
Name: NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1 H-indole-3-carboxylate)
Type: Synthetic cannabinoid
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
|
IV. History
NM2201 (also known as CBL2201), a synthetic cannabinoid, was first identified in the early 2010s. It was developed to mimic THC and interact with cannabinoid receptors. The compound found its way into synthetic cannabis products, leading to its widespread recreational use. NM2201's potent effects and health risks have led to increased regulation.
|
|
V. Legal Information
NM2201 (also known as CBL2201) is a synthetic cannabinoid with high abuse potential. It is classified as a Schedule I controlled substance in the United States and similarly regulated globally to control its misuse and impact on public health. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
NM2201 is a synthetic cannabinoid with potent psychoactive effects. It increases heart rate and blood pressure. Short-term use may produce intense psychoactive effects, while long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation, hallucinations, and cardiovascular effects. Safe use requires cautious dosing and monitoring. Recent research explores its psychoactive effects and associated health risks.  |
|
VII. Psychological Effects
NM2201 (CBL2201) is a synthetic cannabinoid causing euphoria, altered perception, and anxiety. Immediate impacts include paranoia, hallucinations, and cognitive impairment. Long-term use can lead to dependence, severe psychiatric disorders, and cognitive deficits. Recent research indicates higher risks of severe anxiety and psychotic episodes compared to natural cannabinoids.
 |
|
VIII. Culture
NM2201 and CBL2201 are synthetic cannabinoids with no historical lore, emerging in the 21st century. Their significance is tied to their role as legal highs and associated health risks. Proponents may discuss their effects and availability, while opponents focus on health dangers and regulatory challenges. Their use is primarily recreational, reflecting broader concerns about synthetic drugs.
 |